PLOSMedicine: Global recommendations on child #essentialmedicines should show supporting evidence: #Ghana @PLOSMedicine case study: http://t.co/kTCBs336qX
PLOSPathogens: Very excited for the beginning of #KSimmunity today in Ouro Preto. Make sure to say hello if you see anyone with a PLOS button!
PLoSNTDs: Stinky socks attract P. falciparum-infected An. gambiae? So states new report in @PLOSONE via @latimesscience
http://t.co/pWXLV6lusz
-
Image Credit: Alberto G.
Blog Archives
India’s patent law on trial
Category: General, MSF
Tagged global health, health costs, health policy, MSF, pharmaceutical industry
4 Comments
This week in PLoS Medicine: HIV resistance in women treated with nevirapine; Charging less for more effective treatments; Developing guidelines for better reporting
Category: General
Tagged Cost-Effective, guidelines, health costs, HIV, Nevirapine, reporting, research quality, Value-Based Insurance Design
Leave a comment
This week in PLoS Medicine: Cost effective strategy for HIV prevention; Analysis of immune responses to Plasmodium falciparum; Malaria—Linking knowledge with action
Category: General
Tagged Global Health Systems, health costs, malaria, male circumcision and HIV, Neonatal, Plasmodium Falciparum
Leave a comment
Cheaper malaria drugs but more stockouts in Africa?
Category: PLoS Medicine's Daily Click
Tagged antimicrobial drugs, developing world, health costs, malaria, Policy
Leave a comment
Diving into the patent pool
Category: Access, Policy, Public
Tagged antimicrobial drugs, developing world, health costs, HIV, pharmaceutical industry, Policy
1 Comment